The Global Fund and partners began rollout of 5,000 PlusLife MiniDock Ultra near point-of-care TB test systems across 13 countries supported by $50 million from the Children’s Investment Fund Foundation. The MiniDock Ultra deployments are intended to expand access to rapid TB testing in settings where lab capacity can be limited. The programmatic start focuses on multi-country scale-up rather than a single-country pilot, reflecting an operational push to move diagnostics closer to patients. PlusLife’s MiniDock Ultra is designed for decentralized workflows, and the rollout includes the equipment supply coordinated with Global Fund operations. For biotech and diagnostics stakeholders, the rollout demonstrates continued donor and multilateral support for point-of-care infectious disease infrastructure as procurement volumes build across endemic regions.